Information Journal Paper
APA:
Copy. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. CELL, 181(2), 271-280. SID. https://sid.ir/paper/747947/en
Vancouver:
Copy. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. CELL[Internet]. 2020;181(2):271-280. Available from: https://sid.ir/paper/747947/en
IEEE:
Copy, “SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor,” CELL, vol. 181, no. 2, pp. 271–280, 2020, [Online]. Available: https://sid.ir/paper/747947/en